ArticleiScience2026
A gut feeling: Exploring the effects of probiotics on risk-taking behavior using TMS.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the impact of the gut-brain axis (GBA) on risk-taking through a 4-week, double-blinded, placebo-controlled probiotics protocol and the Maastricht Gambling Task (MGT). We used transcranial magnetic stimulation (TMS) on the ventromedial prefrontal cortex (VMPFC), a region thought to mediate GBA signals in risk-related decisions. Continuous theta burst stimulation (cTBS) targeted the VMPFC, with the superior parietal lobule (SPL) and sham as control conditions, applied before and after the probiotics/placebo intervention. Results show that probiotics significantly increased risky choices and response times in the MGT compared to placebo, without reducing choice optimality. VMPFC stimulation, independent of probiotics intake, also led to riskier choices when controlling for task repetition. The nonsignificant interaction between probiotics and VMPFC stimulation suggests that the VMPFC does not play a key functional role in the effects of probiotics on risk-taking behavior. These findings offer insights into GBA influences on human decision-making through probiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.